Hematology & Oncology Doctors in Riverhead, NY Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Dr. Yelda Nouri, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 750 Old Country Road Building 2, Riverhead, NY 11901 Phone: 631-751-3000    Fax: 631-509-6559

Dr. Roy Ho Hsin Chen, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 750 Old Country Road Building 2, Riverhead, NY 11901 Phone: 631-751-3000    Fax: 631-675-2001

Neal Murphy, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 750 Old Country Rd Bldg 2, Riverhead, NY 11901 Phone: 631-751-3000    Fax: 631-751-0506

Dr. Susan S Emanuele, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1267 E Main St, Suite A, Riverhead, NY 11901 Phone: 631-727-7100    Fax: 631-727-6754

Dr. Alexander I Zuhoski, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 750 Old Country Road Building 2, Riverhead, NY 11901 Phone: 631-751-3000    Fax: 631-509-6559

News Archive

Anti-oestrogen drugs may promote more harmful cancer cell behaviour

The authors found that tamoxifen can promote an invasive phenotype in ER+ breast cancer cells under conditions of poor cell-cell contact, a previously unknown effect of this drug

Business and insurers' groups back health reform, but not all legislation

A group of CEOs, the Business Roundtable and America's Health Insurance Plans, the insurance industry group, separately expressed qualified support for health overhaul efforts Thursday.

Antidepressants cause mood elevation and behavioral activation in children and adolescents

A paper published in the current issue of P&P by a group of researchers of the University of Bologna (headed by Professor Giovanni Fava) and a Harvard psychopharmacologist (professor Ross Baldessarini) has analyzed data that derive from randomized controlled trials concerned with the use of antidepressant drugs in children and adolescents.

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.

Studies identify factors that may lead teens to drive with multiple peer passengers

A pair of studies by The Children's Hospital of Philadelphia (CHOP) and State Farm® identify factors that may lead teens to drive with multiple peer passengers and, then, how those passengers may affect their driver's behavior just before a serious crash. The studies were published today in the Journal of Adolescent Health.

Read more Medical News

› Verified 7 days ago